from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2912c/-

LFCtreatmentdescriptionclass of inhibitor

0.352

Amikacinug/mL Amikacintranslation

0.043

Cap5-10ug/mL Capreomycintranslation

-0.066

Rox10-50 ug/mL Roxithromycintranslation

1.828

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.114

Rif0.2-5ug/mL Rifampicintranscription

0.315

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.295

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.124

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.079

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.690

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.463

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.127

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.272

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.126

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.145

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.268

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.087

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.352

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.162

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.435

KCN5-20 ug/mL Potassium cyaniderespiration

0.783

NaN30.2-2 mM Sodium aziderespiration

-0.206

Nigericin50 uM Nigericinrespiration

0.857

TRC10-150 ug/mL Triclosanrespiration

-0.355

TRZ10-25 ug/mL Thioridazinerespiration

2.409

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.047

menadione6-10 ug/mL Menadionerespiration

0.147

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.825

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.487

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.127

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.982

NRP_1Non-replicating persistence stage 1dosRassociated

0.415

Amp0.2mg/mL AmpicillincellWall

-0.402

Cephalexin20-100 ug/mL CephalexincellWall

0.032

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.152

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.670

EMB10-20 ug/mL EthambutolcellWall

-0.031

Eta12-40 ug/mL EthionamidecellWall

0.106

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.150

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.132

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.121

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.719

BZA0.12 mg/mL BenzamidearomaticAmides

-0.088

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.092

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.019

H2O24 mM hydrogen peroxideDNAdamaging

0.017

Levo10 ug/mL LevofloxacinDNAdamaging

-0.405

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.786

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.086

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.266

UVUV-irradiationDNAdamaging

0.003

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.615

Antimycin12.5-50 ug/mL Antimycin A?

-0.480

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.175

PA_110-50 ug/mL Antitubercular compound PA-1?

0.040

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.801

PA8240.2-2 ug/mL PA-824?

-0.470

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.265

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.313

Verapamil50 uM Verapamil?

-0.176

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.313

methoxatin10-20 ug/mL Methoxatin?